9 METERS BIOPHARMA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NMTRQ and buy or sell other stocks, ETFs, and their options commission-free!About NMTRQ
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.
CEOBethany L. Sensenig, MBA
CEOBethany L. Sensenig, MBA
Employees10
Employees10
HeadquartersRaleigh, North Carolina
HeadquartersRaleigh, North Carolina
Founded2012
Founded2012
Employees10
Employees10
NMTRQ Key Statistics
Market cap1.45K
Market cap1.45K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume55.80K
Average volume55.80K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0005
52 Week high$0.0005
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 1.45K, 9 METERS BIOPHARMA INC(NMTRQ) trades at $0.00.
9 METERS BIOPHARMA INC(NMTRQ) stock opened on 2026-06-08 at —. The price climbed to — and dipped to —.
The 9 METERS BIOPHARMA INC(NMTRQ)'s current trading volume is 0, compared to an average daily volume of 55.8K.
In the last year, 9 METERS BIOPHARMA INC(NMTRQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, 9 METERS BIOPHARMA INC(NMTRQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own NMTRQ. This list is generated using Robinhood data, and it’s not a recommendation.